1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
607E2317F34534A4200258A7B003EF6D1
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/07E2317F34534A4200258A7B003EF6D1?OpenDocument
18
19OpenDocument
2044.201.97.138
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Competitive and Business Intelligence » Structure and Alignment

Document Excerpt: Strategic Operations in Competitive Intelligence: Models, Reporting, Performance, and Structure Trends

DB Image

ID: MD-882


Features:

6 Info Graphics

13 Data Graphics

140+ Metrics

9 Narratives


Pages/Slides: 4


Published: 2023


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5782 “Strategic Operations in Competitive Intelligence: Models, Reporting, Performance, and Structure Trends”.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Manufacturing; Biotech; Consumer Products; Medical Device; Biopharmaceutical; Chemical; Clinical Research; Laboratories


Companies Profiled:
Abbott; AbbVie; Bayer; BioMarin; Biotest AG; Cerevel Therapeutics; Clovis Oncology; CSL Behring; Daiichi Sankyo; Genentech; Ipsen; Kala Pharmaceuticals; Inc.; Novartis; Novo Nordisk; Paratek Pharmaceuticals; Pfizer; Regeneron; SCIEX; Sanofi; Servier; Takeda Pharmaceuticals; Vincerx Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.